Načítá se...
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...
Uloženo v:
| Vydáno v: | BMC Res Notes |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4222084/ https://ncbi.nlm.nih.gov/pubmed/24267160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-484 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|